Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serum Tumor Markers”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableEnded earlyNCT00942058
What this trial is testing

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Centre Hospitalier Universitaire de Saint Etienne 16
Not applicableStudy completedNCT06686966
What this trial is testing

Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers

Who this might be right for
Gastric Cancers
First Affiliated Hospital of Chongqing Medical University 3,400
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Post-approval studies (Phase 4)Study completedNCT00334139
What this trial is testing

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Who this might be right for
Prostate CancerBreast CancerBone Metastasis
Novartis Pharmaceuticals 411
Not applicableLooking for participantsNCT06060990
What this trial is testing

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Who this might be right for
Trace Element Deficiency
Institute of Oncology Ljubljana 20
Not applicableActive Not RecruitingNCT06897722
What this trial is testing

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

Who this might be right for
Psoriasis (PsO)Periodontal Disease
Zhala Vatankha Sain 100
Not applicableLooking for participantsNCT01042548
What this trial is testing

Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

Who this might be right for
Breast Cancer
University of Pittsburgh 300
Not applicableActive Not RecruitingNCT04705389
What this trial is testing

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

Who this might be right for
Merkel Cell Carcinoma
University Hospital, Tours 35
Not applicableStudy completedNCT02553850
What this trial is testing

An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 442
Not applicableLooking for participantsNCT06015802
What this trial is testing

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

Who this might be right for
Pituitary AdenomaNeuroendocrine Tumors
Sun Yat-sen University 300
Not applicableWithdrawnNCT06200441
What this trial is testing

Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease

Who this might be right for
Acute Myeloid Leukemia, AdultGraft Versus Host DiseaseEndothelial Dysfunction
Ugur Arzu Kulu
Not applicableStudy completedNCT07115095
What this trial is testing

Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Nanlin Li 98
Testing effectiveness (Phase 2)Study completedNCT00001568
What this trial is testing

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities

Who this might be right for
Colorectal Neoplasm
National Cancer Institute (NCI) 200
Not applicableStudy completedNCT01212510
What this trial is testing

Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Rouen 200
Not applicableStudy completedNCT03661801
What this trial is testing

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions

Who this might be right for
Respiratory DiseasePleural EffusionLung Cancer
University of Oxford 313
Not applicableNot Yet RecruitingNCT07837063
What this trial is testing

Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment.

Who this might be right for
CancerUrology
The Clatterbridge Cancer Centre NHS Foundation Trust 40
Large-scale testing (Phase 3)Study completedNCT00171704
What this trial is testing

Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Who this might be right for
Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women
Novartis Pharmaceuticals 263
Post-approval studies (Phase 4)Study completedNCT00391690
What this trial is testing

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis 99
Not applicableUnknownNCT05152407
What this trial is testing

MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis

Who this might be right for
Actinic KeratosisActinic Lentigo
NAOS Institute of Life Science 35
Not applicableStudy completedNCT00373347
What this trial is testing

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Stanford University 573
Next Page